O Nettelbladt
Overview
Explore the profile of O Nettelbladt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shahana S, Bjornsson E, Ludviksdottir D, Janson C, Nettelbladt O, Venge P, et al.
Respir Med
. 2005 Mar;
99(4):429-43.
PMID: 15763449
Epithelial damage is commonly found in airways of asthma patients. The aim of this study was to investigate epithelial damage in allergic and non-allergic asthma at the ultrastructural level. Bronchial...
2.
Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Gudbjornsson B, Valtysdottir S, et al.
Respir Med
. 2001 Nov;
95(11):904-10.
PMID: 11716205
The present study aimed to compare the cellular pattern and structural changes in the airways of patients with primary Sjögren's syndrome (pSS) with healthy controls. Bronchial biopsy specimens were obtained...
3.
Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans G, et al.
Am J Respir Crit Care Med
. 2000 Dec;
162(6):2295-301.
PMID: 11112154
The aim of the present study was to compare the cellular pattern and structural changes in the airway walls of atopic and nonatopic patients with asthma. Bronchial biopsy specimens were...
4.
Hillerdal G, Lofdahl C, Orre L, Skoogh B, Gyllstedt E, Strom K, et al.
Lakartidningen
. 1996 Oct;
93(44):3910, 3915-6.
PMID: 8965580
No abstract available.
5.
Bjermer L, Frojd O, Nettelbladt O, Karlsson-Parra A, Henriksson R
Eur Respir J
. 1995 Nov;
8(11):1872-8.
PMID: 8620955
In recent years, interleukin-2 (IL-2) has been used as an immunomodulatory agent in the treatment of various malignant tumours. However, this treatment has been limited by serious side-effects, including toxic...
6.
Teder P, Nettelbladt O, Heldin P
Am J Respir Cell Mol Biol
. 1995 Feb;
12(2):181-9.
PMID: 7532420
The molecular mechanisms behind the accumulation of hyaluronan during bleomycin-induced lung injury in rats were investigated. The stimulatory effects of bronchoalveolar lavage fluid (BALF) and alveolar macrophage (AM)-conditioned media on...
7.
Gudbjornsson B, Hallgren R, Nettelbladt O, Gustafsson R, Mattsson A, af Geijerstam E, et al.
Ann Rheum Dis
. 1994 Sep;
53(9):574-9.
PMID: 7979595
Objectives: Attempts to differentiate between the pathogenesis of the severe pulmonary manifestations observed in systemic sclerosis (SSc) and the mild form in primary Sjögren's syndrome (pSS) were performed by studying...
8.
Hernnas J, Nettelbladt O, Bjermer L, Sarnstrand B, Malmstrom A, Hallgren R
Eur Respir J
. 1992 Apr;
5(4):404-10.
PMID: 1373389
The development of bleomycin-induced pulmonary fibrosis in rats was studied over a period of 30 days after an intratracheal instillation of bleomycin. Fibronectin was visualized in histological sections and quantified...
9.
Hillerdal G, Frisk G, Nettelbladt O, DIDERHOLM H
Sarcoidosis
. 1992 Mar;
9(1):39-42.
PMID: 1344042
By using radioimmunoassay (RIA) for detection of IgM antibodies to Coxsackie B viruses (CBV), the occurrence of these antibodies was investigated in patients with sarcoidosis and asbestos-related lesions. Sixty-one per...
10.
Gustafsson R, Fredens K, Nettelbladt O, Hallgren R
Arthritis Rheum
. 1991 Apr;
34(4):414-22.
PMID: 1849409
Circulating levels of eosinophil cationic protein (ECP) were increased 4-fold in patients with systemic sclerosis (SSc) compared with those in healthy control subjects. There was no correlation between the ECP...